Boston, MA, United States of America

Xiao Jian Sun

This inventor holds 1 USPTO granted patent. Top assignee: Joslin Diabetes Center, Inc.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiao Jian Sun. Retrieved from https://idiyas.com/inventor/xiao-jian-sun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Xiao Jian Sun

Introduction

Xiao Jian Sun is a notable inventor based in Boston, MA. He has made significant contributions to the field of biotechnology, particularly in diabetes research. His work has led to advancements that may improve the understanding and treatment of insulin-related conditions.

Latest Patents

Xiao Jian Sun holds a patent for "DNA encoding an insulin receptor substrate." This patent includes a substantially pure nucleic acid comprising a sequence encoding an IRS-2 polypeptide, a substantially pure preparation of an IRS-2 polypeptide, and related methods. This innovation is crucial for further research in insulin signaling pathways.

Career Highlights

He is currently affiliated with the Joslin Diabetes Center, Inc., where he continues to explore the complexities of diabetes and its treatment. His research has the potential to impact the lives of many individuals affected by this condition.

Collaborations

Xiao Jian Sun has collaborated with esteemed colleagues such as Morris F. White and Jacalyn H. Pierce. These partnerships have fostered a productive research environment, leading to significant advancements in their field.

Conclusion

Xiao Jian Sun's contributions to diabetes research through his innovative patent and collaborations highlight his role as a key figure in biotechnology. His work continues to pave the way for future advancements in the treatment of diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…